Diabetes, Vol 36, Issue 8 932-937, Copyright © 1987 by American Diabetes Association
Alpha-adrenergic blockade improves glucose-potentiated insulin secretion in non-insulin-dependent diabetes mellitus
VL Broadstone, MA Pfeifer, V Bajaj, JI Stagner and E Samols
The impairment of glucose-potentiated insulin secretion present in
non-insulin-dependent diabetes mellitus (NIDDM) can be approximated in
normal subjects by an epinephrine infusion. Therefore, we sought to
determine the role of the endogenous sympathetic nervous system in
glucose-potentiated insulin secretion in both NIDDM (n = 6) and normal (n =
6) subjects. Glucose-potentiated insulin secretion was calculated as the
slope of the curve relating increasing ambient glucose levels to the acute
insulin response to an intravenous pulse of 5 g of L-arginine.
Glucose-potentiated insulin secretion was determined on separate days
during alpha-, beta-, and combined alpha- plus beta-adrenergic blockade and
compared with a saline control. In normal subjects, there was no effect of
alpha-, beta-, or alpha- plus beta-blockade on the slope of glucose
potentiation. In NIDDM, the initially decreased slope of glucose
potentiation (0.25 +/- 0.06 microU X ml-1 X mg-1 X dl, mean +/- SE; P less
than .01) was not affected by beta-blockade but increased during
alpha-blockade (0.91 +/- 0.22 microU X ml-1 X mg-1 X dl; P less than .05).
However, this improvement was abolished by combined alpha- plus
beta-blockade (0.32 +/- 0.07 microU X ml-1 X mg-1 X dl). Plasma
norepinephrine was increased above basal levels in both normal (+260 +/- 89
pg/ml) and NIDDM (+438 +/- 162 pg/ml) subjects during alpha-blockade (P
less than .05 for both). This increase in plasma norepinephrine strongly
suggests that there is an increase in synaptic cleft norepinephrine
concentration.(ABSTRACT TRUNCATED AT 250 WORDS)